Schedule 13D ownership disclosure
ARROWHEAD RESEARCH CORP
Security class unavailable · CUSIP: 042797209
Event date: 2017-11-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,321,383
- Percent of class
- 4.4400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-17-070618
- Form type
- SC 13D
- Filer
- ARROWHEAD PHARMACEUTICALS, INC.
- CIK
- CIK 879407
- Filed
- Nov 28, 2017
- Reporting period
- Nov 28, 2017
- Description
- Schedule 13D beneficial ownership